Status:
UNKNOWN
Multiple Myeloma (MM) Quality of Life (QOL) Study
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Kully Family Foundation
Conditions:
Multiple Myeloma
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to examine differences in quality of life and psychological distress for both Multiple Myeloma patients receiving treatment and their caregivers and to assess patient...
Detailed Description
This research study's procedures include screening for eligibility, participant designation of a caregiver and a series of questionnaires. \- It is expected that about 180 people undergoing treatment...
Eligibility Criteria
Inclusion
- Patient Eligibility criteria:
- Adult patients (greater than 18 years) receiving active therapy for MM.
- For patients with newly diagnosed MM, patients are eligible while undergoing induction therapy prior to received autologous stem cell transplant but not after.
- Ability to read questions in English or willing to complete questionnaires with the assistance of an interpreter.
- Caregiver Eligibility criteria:
- Adult (greater than 18 years) relative or a friend of a patient who agrees to participate in the study whom the patient identified as living with them or having in-person contact with him or her at least twice per week.
- Ability to read and respond to questions in English or to complete questionnaires with minimal assistance of an interpreter
Exclusion
- Patient Exclusion criteria:
- Patients receiving maintenance therapy only.
- Significant psychiatric or other co-morbid disease, which the treating clinician believes prohibits informed consent or participation in the study.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 16 2022
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04388735
Start Date
June 1 2020
End Date
May 16 2022
Last Update
May 14 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114
2
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
3
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215